A breakthrough for diabetes management arrived on March 6th with the FDA‘s approval of Dexcom’s Stelo glucose biosensor system. This revolutionary device, the first of its kind, allows for over-the-counter, prescription-free blood sugar monitoring for individuals with non-insulin-dependent diabetes or those at risk of developing the condition.

The glucose monitor displays readings every 15 minutes

Unlike traditional methods, Stelo utilizes a wearable sensor and smartphone app to continuously monitor glucose levels, displaying readings every 15 minutes. Each sensor lasts up to 15 days before needing replacement, offering a convenient and long-lasting solution.

The FDA highlighted the significance of this approval, emphasizing its potential to increase accessibility to blood sugar monitoring and empower individuals to manage their health from the comfort of their homes.

While Stelo represents a major step forward, the ultimate goal in diabetes management remains non-invasive blood glucose monitoring. This technology, though initially planned for the Apple Watch, has yet to be realized due to current limitations. The FDA also cautions against unapproved non-invasive alternatives, stressing their unreliability.

Despite the current absence of non-invasive options, Dexcom’s Stelo marks a significant advancement in diabetes management, offering a convenient and accessible solution for many people. The future of blood sugar monitoring, however, holds the promise of even more innovative and non-invasive approaches.

RELATED:

• Samsung Galaxy Watch receives FDA approval for sleep apnea detection
• Neuralink Receives Approval from FDA for Human Testing
• Get latest Oneplus 12 Phone for $699 on Geekwills
• Get $100 OFF on Xiaomi 14 Pro at Giztop (1TB Variant)
• Lenovo Legion Y700 2023: Save $100 on this 8-inch gaming Android tablet
• How to add/remove someone in a WhatsApp group (with screenshots)

(Via)

The post FDA Approves First OTC Glucose Monitor, Dexcom’s Stelo System – and it can Pair with your Smartphone appeared first on Gizmochina.

Non-invasive Blood Glucose Monitoring is a technology that hasn’t quite matured yet. However, a report by ETNews says that Apple and Samsung might finally be able to implement “Blood sugar monitoring” on their next smartwatches.

The report says that both Samsung and Apple will introduce the non-conventional method of Blood Sugar monitoring on their Galaxy Watch 4/Watch Active 3 and Watch 7* respectively. That is, the glucometer inside the smartwatches will apparently be based on an optical sensor.

This is not the first time we are hearing about this. A couple of weeks ago, we saw a company called Quantum Operation showing off a “Spectrometer-based” prototype that works on the interaction of light with the wrist. We already know that companies like Apple have been actively working on it for more than a year now.

And to affirm this, the report says that both of them have secured their patents and are now working on increasing the reliability. Apple’s patent dates back to 2018 whereas Samsung collaborated with MIT to post results of Raman’s Spectroscopy on journal “Science Advances”.

For the unware, it is how a Light interacts with chemical bonds of a material. When you irradiate laser light onto a substance, it scatters. These differing wavelengths can be used to monitor the Blood Glucose accurately than before. If the report is true, Diabetic patients can finally be free of having to constantly prick their fingers with needles.

Samsung and Apple are the right companies to popularise this as others despite advancing aren’t really progressing beyond prototypes. That said, both the companies will reportedly introduce this as early as this year. Out of this, Samsung is planning three new watches in H2 2021 and one/two might get this feature.

With Smartwatches pressing the saddle in 2021, I think this is the right time to introduce a game-changing feature on wearables.

*- Smartwatches’ Names are Tentative.

RELATED:

• Samsung Galaxy A52 and Galaxy A7 2 prices leaked for Europe
• Apple to cross $100 billion in sales in Q4 2020: Report
• The Best Smartwatches and Fitness Trackers of 2020

(via)

The post Samsung Galaxy Watch 4/Watch Active 3, Apple Watch 7 could get ‘Blood Sugar’ Monitoring feature appeared first on Gizmochina.